Characterization of INCB086550, a Potent and Novel Small-Molecule PD-L1 Inhibitor

0
61
Scientists described the identification and characterization of INCB086550, a novel, oral, small-molecule PD-L1 inhibitor.
[Cancer Discovery]
Abstract